NJ State Employees Deferred Compensation Plan - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 96 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$5,496
+0.7%
30,0000.0%0.00%0.0%
Q4 2023$5,460
-38.9%
30,0000.0%0.00%0.0%
Q3 2023$8,940
+80.1%
30,0000.0%0.00%0.0%
Q2 2023$4,965
-83.0%
30,0000.0%0.00%
-80.0%
Q1 2023$29,280
-6.2%
30,0000.0%0.01%0.0%
Q4 2022$31,200
-10.9%
30,0000.0%0.01%
-16.7%
Q3 2022$35,000
-37.5%
30,0000.0%0.01%
-33.3%
Q2 2022$56,000
-38.5%
30,0000.0%0.01%
-25.0%
Q1 2022$91,000
-19.5%
30,0000.0%0.01%
-14.3%
Q4 2021$113,000
-27.1%
30,0000.0%0.01%
-33.3%
Q3 2021$155,000
+34.8%
30,0000.0%0.02%
+40.0%
Q2 2021$115,000
+49.4%
30,0000.0%0.02%
+36.4%
Q1 2021$77,000
+2.7%
30,0000.0%0.01%
-8.3%
Q4 2020$75,000
+21.0%
30,0000.0%0.01%
+9.1%
Q3 2020$62,000
-33.3%
30,0000.0%0.01%
-35.3%
Q2 2020$93,000
+36.8%
30,0000.0%0.02%
+6.2%
Q1 2020$68,000
-37.6%
30,0000.0%0.02%
-15.8%
Q4 2019$109,000
+6.9%
30,0000.0%0.02%0.0%
Q3 2019$102,00030,0000.02%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$1,779,2050.70%
1620 INVESTMENT ADVISORS, INC. 4,421$317,6050.35%
CM Management, LLC 750,000$136,5000.11%
BVF INC/IL 20,609,863$3,750,9950.09%
NorthStar Asset Management LLC /NJ/ 39,065$7,1100.01%
XTX Topco Ltd 39,689$7,2230.00%
NJ State Employees Deferred Compensation Plan 30,000$5,4600.00%
Virtu Financial LLC 90,059$160.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$1740.00%
OSAIC HOLDINGS, INC. 516$940.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders